Skip to main content
Clinical Trials/ITMCTR2000003353
ITMCTR2000003353
Not yet recruiting
Phase 1

The biomechanical effectiveness of the Taichi exercise in the management of knee OA

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • The diagnostic criteria of KOA refer to the guidelines for the diagnosis and treatment of osteoarthritis (2018 edition) formulated by the Chinese society of traditional Chinese medicine in 2018\.
  • (1\) repeated pain in past one month;
  • (2\) X\-ray film (standing position or weight\-bearing position) showed knee joint space narrowing, subchondral osteosclerosis and/or cystic change, osteophyte formation at joint edge;
  • (3\) Aged 40\-70 years;
  • (4\) The morning stiffness time \<\=30min;
  • (5\) With bone friction sound (feeling).
  • Meet (1\) \+ any 2 of (2\), (3\), (4\), (5\) iteams can be diagnosed as knee osteoarthritis.

Exclusion Criteria

  • 1\. Previous hip/knee replacement surgery or planning to undergo hip/knee surgery during the trial;
  • 2\. Patients with knee joint tumor, tuberculosis, suppuration and disease affecting joint structure and function;
  • 3\. Patients with diseases that hinder participation in and influence the completion of the study, such as myocardial infarction or stroke, congestive failure, severe chronic obstructive pulmonary disease, cancer, diabetes, severe systemic disease, and severe mental illness in the past three months;
  • 4\. Any test drugs being used in the past 30 days;
  • 5\. at the same time to participate in other clinical trials, unable to complete the instruments.

Outcomes

Primary Outcomes

Not specified

Similar Trials